Susann-Cathrin Olthof
Overview
Explore the profile of Susann-Cathrin Olthof including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olthof S, Weiland E, Benkert T, Wessling D, Leyhr D, Afat S, et al.
Diagnostics (Basel)
. 2024 Aug;
14(16).
PMID: 39202230
The objective of this study was to evaluate a high-resolution deep-learning (DL)-based diffusion-weighted imaging (DWI) sequence for breast magnetic resonance imaging (MRI) in comparison to a standard DWI sequence (DWI)...
2.
Werner S, Sekler J, Guckel B, Fougere C, Nikolaou K, Pfannenberg C, et al.
Diagnostics (Basel)
. 2023 Jul;
13(14).
PMID: 37510164
There is a lack of evidence regarding the clinical impact of [F]fluorodeoxyglucose positron emission tomography/computed tomography ([F]FDG-PET/CT, hereinafter referred to as PET/CT), especially regarding management changes and their link to...
3.
Wessling D, Gassenmaier S, Olthof S, Benkert T, Weiland E, Afat S, et al.
Eur J Radiol
. 2023 Jul;
166:110948.
PMID: 37481831
Purpose: This study aimed to assess the technical feasibility, the impact on image quality, and the acquisition time (TA) of a new deep-learning-based reconstruction algorithm in diffusion weighted imaging (DWI)...
4.
Wessling D, Mannlin S, Schwarz R, Hagen F, Brendlin A, Olthof S, et al.
Eur Radiol
. 2022 Dec;
33(4):2945-2953.
PMID: 36474057
Objective: To evaluate the impact of the digital mammography imaging system on overall background enhancement on recombined contrast-enhanced spectral mammography (CESM) images, the overall background enhancement of two different mammography...
5.
Olthof S, Wessling D, Winkelmann M, Rempp H, Nikolaou K, Hoffmann R, et al.
Insights Imaging
. 2022 Mar;
13(1):48.
PMID: 35312842
Background: Radiofrequency ablation (RFA) is a minimal-invasive, local therapy in patients with circumscribed metastatic disease. Although widely used, long time survival analysis of treated liver metastases is still pending while...
6.
Olthof S, Reinert C, Nikolaou K, Pfannenberg C, Gatidis S, Benkert T, et al.
Insights Imaging
. 2021 Nov;
12(1):175.
PMID: 34817715
Background: Detection of pulmonary nodules in MRI requires fast imaging strategies without respiratory motion impairment, such as single-breath-hold Cartesian VIBE. As patients with pulmonary diseases have limited breath-hold capacities, this...
7.
Olthof S, Krumm P, Weichold O, Eigentler T, Bosmuller H, Fougere C, et al.
Eur J Radiol
. 2020 Sep;
131:109242.
PMID: 32942199
Purpose: To evaluate the potential of CT texture analysis parameters and metabolic characteristics of melanoma metastases in F- FDG PET/CT to predict relevant mutations of tumour cells for targeted therapy...
8.
Olthof S, Forschner A, Martus P, Garbe C, Nikolaou K, Fougere C, et al.
Eur J Nucl Med Mol Imaging
. 2020 Mar;
47(10):2313-2321.
PMID: 32123968
Purpose: To evaluate the clinical benefit of positron emission tomography (PET)/computed tomography (CT) in patients with advanced melanoma, primarily not selected for surgery based on management changes and survival data...
9.
Schwenck J, Olthof S, Pfannenberg C, Reischl G, Wegener D, Marzec J, et al.
J Nucl Med
. 2019 Mar;
60(10):1359-1365.
PMID: 30850491
Biochemical recurrence (BCR) after prostate cancer surgery is common, even after additional salvage radiotherapy. BCR might be explained by target miss. Improved diagnostic accuracy provided by PET could potentially circumvent...
10.
Pfannenberg C, Gueckel B, Wang L, Gatidis S, Olthof S, Vach W, et al.
Eur J Nucl Med Mol Imaging
. 2018 Oct;
46(1):54-64.
PMID: 30269155
Purpose: The purpose of this study was to evaluate the impact of PET/CT on clinical management of cancer patients based on a prospective data registry. The study was developed to...